Graeme J. Moyle

Corporate Officer/Principal at Chelsea & Westminster Hospital

60 year

Health Technology

Consumer Services

Graeme J. Moyle active positions

Companies	Position	Start	End
Chelsea & Westminster Hospital	Corporate Officer/Principal	1993-12-31	-

Companies	Position	Start	End
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Director/Board Member	2014-06-22	-
	Independent Dir/Board Member	2014-06-22	-

University of Adelaide

Doctorate Degree

International

Operational

Director/Board Member	1
Independent Dir/Board Member	1
Doctorate Degree	1

Sectoral

Health Technology	2
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	2
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Health Technology
Chelsea & Westminster Hospital

Private companies

Health Technology

Chelsea & Westminster Hospital